Catalyst Pharmaceuticals Inc (CPRX)
Debt-to-assets ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total assets | US$ in thousands | 470,114 | 375,630 | 237,788 | 192,354 | 112,376 |
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2023 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $470,114K
= 0.00
Based on the data provided for Catalyst Pharmaceuticals Inc, the debt-to-assets ratio has consistently been 0.00 for the past five years, including at the end of 2023. A debt-to-assets ratio of 0.00 indicates that the company has no debt relative to its total assets. This suggests that Catalyst Pharmaceuticals Inc has been operating with a conservative capital structure, relying more on equity financing rather than debt to fund its operations and investments. A low or zero debt-to-assets ratio can be viewed positively by investors and creditors as it signifies lower financial risk and potential for financial stability. However, it is essential to consider other financial metrics and factors such as profitability, liquidity, and operating efficiency in conjunction with the debt-to-assets ratio to gain a comprehensive understanding of the company's financial health and performance.
Peer comparison
Dec 31, 2023